Tempest Therapeutics Inc. will hold its Annual Meeting of Stockholders on December 31, 2025. During the meeting, shareholders will vote on the election of the Board's Class I nominee, Geoff Nichol, to the Board of Directors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-043939), on December 02, 2025, and is solely responsible for the information contained therein.
Comments